• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过中间变量控制混杂因素

The control of confounding by intermediate variables.

作者信息

Robins J

机构信息

Occupational Health Program Harvard School of Public Health, Boston, MA 02115.

出版信息

Stat Med. 1989 Jun;8(6):679-701. doi: 10.1002/sim.4780080608.

DOI:10.1002/sim.4780080608
PMID:2749074
Abstract

In epidemiologic studies of the effect of an exposure on disease, the crude association of exposure with disease may fail to reflect a causal association due to confounding by one or more covariates. Most previous discussions of confounding in the epidemiologic literature have considered only point exposure studies, that is, studies that measure exposure and covariate status only once, at start of follow-up. In this paper we offer definitions of confounding suitable for longitudinal studies that obtain data on exposure, covariate, and vital status at several points in time. An important difference between longitudinal studies and point exposure studies is that, in longitudinal studies, a time-dependent covariate can be simultaneously a confounder and an intermediate variable on the causal pathway from exposure to disease. In this paper I propose an estimator, the extended standardized risk difference, that provides control for confounding by a covariate that is simultaneously a confounder and an intermediate variable.

摘要

在关于暴露因素对疾病影响的流行病学研究中,由于一个或多个协变量的混杂作用,暴露因素与疾病之间的粗略关联可能无法反映因果关联。流行病学文献中先前关于混杂的大多数讨论仅考虑了时点暴露研究,即仅在随访开始时测量一次暴露和协变量状态的研究。在本文中,我们给出了适用于纵向研究的混杂定义,这类研究在多个时间点获取暴露、协变量和生命状态的数据。纵向研究与时点暴露研究的一个重要区别在于,在纵向研究中,一个随时间变化的协变量可以同时是混杂因素以及暴露到疾病因果路径上的中间变量。在本文中,我提出了一种估计方法,即扩展标准化风险差,它可以控制同时作为混杂因素和中间变量的协变量的混杂作用。

相似文献

1
The control of confounding by intermediate variables.通过中间变量控制混杂因素
Stat Med. 1989 Jun;8(6):679-701. doi: 10.1002/sim.4780080608.
2
A new criterion for confounder selection.一种新的混杂因素选择标准。
Biometrics. 2011 Dec;67(4):1406-13. doi: 10.1111/j.1541-0420.2011.01619.x. Epub 2011 May 31.
3
Toward a clearer understanding of causal concepts in epidemiology.为了更清晰地理解流行病学中的因果概念。
Ann Epidemiol. 2013 Dec;23(12):743-9. doi: 10.1016/j.annepidem.2013.09.001.
4
Identification of confounder in epidemiologic data contaminated by measurement error in covariates.在协变量存在测量误差的情况下,对受污染的流行病学数据中混杂因素的识别。
BMC Med Res Methodol. 2016 May 18;16:54. doi: 10.1186/s12874-016-0159-6.
5
Covariate balance for no confounding in the sufficient-cause model.协变量在充分病因模型中无混杂的均衡。
Ann Epidemiol. 2018 Jan;28(1):48-53.e2. doi: 10.1016/j.annepidem.2017.11.005. Epub 2017 Nov 23.
6
Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.美国癌症协会关于空气污染颗粒与死亡率关系研究的长期随访及空间分析
Res Rep Health Eff Inst. 2009 May(140):5-114; discussion 115-36.
7
Confounding, causality, and confusion: the role of intermediate variables in interpreting observational studies in obstetrics.混杂因素、因果关系与混淆:中间变量在解释产科观察性研究中的作用
Am J Obstet Gynecol. 2017 Aug;217(2):167-175. doi: 10.1016/j.ajog.2017.04.016. Epub 2017 Apr 17.
8
Indirect assessment of confounding: graphic description and limits on effect of adjusting for covariates.混杂因素的间接评估:图形描述及协变量调整效果的局限性
Epidemiology. 1990 May;1(3):239-46. doi: 10.1097/00001648-199005000-00010.
9
Using generalized additive models to reduce residual confounding.使用广义相加模型减少残余混杂。
Stat Med. 2004 Dec 30;23(24):3781-801. doi: 10.1002/sim.2073.
10
Principles of confounder selection.混杂因素选择原则。
Eur J Epidemiol. 2019 Mar;34(3):211-219. doi: 10.1007/s10654-019-00494-6. Epub 2019 Mar 6.

引用本文的文献

1
Daily or Nondaily Vaping and Smoking Cessation Among Smokers.吸烟者的每日或非每日电子烟使用与戒烟
JAMA Netw Open. 2025 Mar 3;8(3):e250089. doi: 10.1001/jamanetworkopen.2025.0089.
2
Causal Inference With Observational Data and Unobserved Confounding Variables.利用观测数据和未观测到的混杂变量进行因果推断。
Ecol Lett. 2025 Jan;28(1):e70023. doi: 10.1111/ele.70023.
3
Assessing Heterogeneity of Treatment Effect in Real-World Data.评估真实世界数据中治疗效果的异质性。
Ann Intern Med. 2023 Apr;176(4):536-544. doi: 10.7326/M22-1510. Epub 2023 Mar 21.
4
On optimal timing of antenatal corticosteroids: time to reformulate the question.关于产前皮质类固醇的最佳时机:是时候重新制定这个问题了。
Arch Gynecol Obstet. 2023 Oct;308(4):1085-1091. doi: 10.1007/s00404-023-06941-w. Epub 2023 Feb 4.
5
Estimation of marginal structural models under irregular visits and unmeasured confounder: calibrated inverse probability weights.不规则随访和未测量混杂因素下边缘结构模型的估计:校准逆概率加权。
BMC Med Res Methodol. 2023 Jan 7;23(1):4. doi: 10.1186/s12874-022-01831-2.
6
Depression, antiretroviral therapy initiation, and HIV viral suppression among people who inject drugs in Vietnam.越南注射吸毒者中的抑郁、抗逆转录病毒治疗开始和 HIV 病毒抑制。
J Affect Disord. 2021 Feb 15;281:208-215. doi: 10.1016/j.jad.2020.12.024. Epub 2020 Dec 9.
7
Estimating the Effect of Depression on HIV Transmission Risk Behaviors Among People Who Inject Drugs in Vietnam: A Causal Approach.评估抑郁对越南注射吸毒人群中 HIV 传播风险行为的影响:一种因果方法。
AIDS Behav. 2021 Feb;25(2):438-446. doi: 10.1007/s10461-020-03007-9.
8
Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.存在与时间相关的协变量的删失依赖性下风险的双重稳健估计:普伐他汀治疗冠心病一级预防试验的应用。
BMC Med Res Methodol. 2020 Jul 31;20(1):204. doi: 10.1186/s12874-020-01087-8.
9
Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.甲氨蝶呤与吗替麦考酚酯单药治疗非感染性眼部炎症性疾病的疗效比较。
Am J Ophthalmol. 2019 Dec;208:68-75. doi: 10.1016/j.ajo.2019.07.008. Epub 2019 Jul 22.
10
Depressive Symptoms at HIV Testing and Two-Year All-Cause Mortality Among Men Who Inject Drugs in Vietnam.越南注射吸毒者 HIV 检测时的抑郁症状与两年全因死亡率。
AIDS Behav. 2019 Mar;23(3):609-616. doi: 10.1007/s10461-018-2318-8.